[1]
Cavo, M. 2009. Bortezomib therapy for refractory/relapsed multiple myeloma. Hematology Meeting Reports (formerly Haematologica Reports). 1, 8 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v1i8.288.